Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 7 | 2022 | 84 | 2.010 |
Why?
|
| Gene Expression Profiling | 6 | 2023 | 133 | 1.740 |
Why?
|
| Transcriptome | 8 | 2023 | 82 | 1.450 |
Why?
|
| Proteome | 5 | 2023 | 35 | 1.440 |
Why?
|
| RNA, Messenger | 3 | 2022 | 306 | 1.320 |
Why?
|
| Alzheimer Disease | 12 | 2023 | 2036 | 1.280 |
Why?
|
| Algorithms | 3 | 2023 | 345 | 1.180 |
Why?
|
| Cognitive Dysfunction | 8 | 2023 | 990 | 1.000 |
Why?
|
| Brain | 11 | 2023 | 1569 | 0.930 |
Why?
|
| Dementia | 3 | 2022 | 524 | 0.740 |
Why?
|
| Sjogren's Syndrome | 2 | 2020 | 3 | 0.720 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 23 | 0.640 |
Why?
|
| Histones | 1 | 2019 | 31 | 0.630 |
Why?
|
| Blood Proteins | 1 | 2018 | 19 | 0.590 |
Why?
|
| ErbB Receptors | 2 | 2010 | 54 | 0.580 |
Why?
|
| Methotrexate | 1 | 2018 | 38 | 0.580 |
Why?
|
| Antirheumatic Agents | 1 | 2018 | 84 | 0.550 |
Why?
|
| Immunophenotyping | 1 | 2017 | 29 | 0.540 |
Why?
|
| Epigenomics | 1 | 2017 | 18 | 0.540 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 22 | 0.540 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 27 | 0.530 |
Why?
|
| Genome-Wide Association Study | 4 | 2023 | 268 | 0.490 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 254 | 0.470 |
Why?
|
| Models, Genetic | 1 | 2015 | 32 | 0.460 |
Why?
|
| Humans | 28 | 2023 | 25967 | 0.390 |
Why?
|
| Aged | 13 | 2023 | 8732 | 0.370 |
Why?
|
| Phosphoproteins | 1 | 2010 | 25 | 0.350 |
Why?
|
| Amyloid beta-Peptides | 5 | 2023 | 309 | 0.300 |
Why?
|
| Aged, 80 and over | 10 | 2023 | 4641 | 0.300 |
Why?
|
| Models, Biological | 2 | 2010 | 318 | 0.290 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 151 | 0.290 |
Why?
|
| Mass Spectrometry | 2 | 2022 | 33 | 0.270 |
Why?
|
| Male | 15 | 2023 | 14277 | 0.270 |
Why?
|
| Cognition | 5 | 2023 | 1250 | 0.260 |
Why?
|
| Female | 13 | 2023 | 14734 | 0.240 |
Why?
|
| Prefrontal Cortex | 3 | 2023 | 128 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 366 | 0.230 |
Why?
|
| Quantitative Trait Loci | 2 | 2021 | 44 | 0.220 |
Why?
|
| Cluster Analysis | 1 | 2023 | 43 | 0.210 |
Why?
|
| Benchmarking | 1 | 2023 | 31 | 0.210 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2023 | 4 | 0.210 |
Why?
|
| Phosphorylation | 4 | 2017 | 143 | 0.200 |
Why?
|
| Neurofibrillary Tangles | 2 | 2023 | 186 | 0.190 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 15 | 0.190 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 4 | 0.190 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 115 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 17 | 0.180 |
Why?
|
| Schizophrenia | 2 | 2011 | 50 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2021 | 66 | 0.170 |
Why?
|
| Peptides | 1 | 2021 | 100 | 0.170 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2020 | 3 | 0.170 |
Why?
|
| Proteins | 1 | 2020 | 60 | 0.170 |
Why?
|
| tau Proteins | 4 | 2023 | 225 | 0.170 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 179 | 0.160 |
Why?
|
| Parkinsonian Disorders | 1 | 2023 | 213 | 0.160 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 266 | 0.160 |
Why?
|
| Acetylation | 1 | 2019 | 15 | 0.160 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 171 | 0.160 |
Why?
|
| Sleep Deprivation | 1 | 2019 | 41 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 25 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2019 | 43 | 0.150 |
Why?
|
| Pyrimidines | 2 | 2017 | 23 | 0.150 |
Why?
|
| Neuropsychological Tests | 2 | 2019 | 1150 | 0.150 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2018 | 3 | 0.150 |
Why?
|
| Seasons | 1 | 2018 | 22 | 0.150 |
Why?
|
| Infliximab | 1 | 2018 | 17 | 0.150 |
Why?
|
| Up-Regulation | 1 | 2019 | 168 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 12 | 0.150 |
Why?
|
| Cell Count | 1 | 2018 | 80 | 0.150 |
Why?
|
| Genotype | 1 | 2019 | 339 | 0.150 |
Why?
|
| Remission Induction | 1 | 2018 | 90 | 0.150 |
Why?
|
| Monocytes | 1 | 2018 | 52 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2018 | 57 | 0.140 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2019 | 114 | 0.140 |
Why?
|
| Independent Living | 1 | 2020 | 283 | 0.140 |
Why?
|
| Phenotype | 3 | 2023 | 290 | 0.140 |
Why?
|
| Neutrophils | 1 | 2018 | 95 | 0.140 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 86 | 0.140 |
Why?
|
| Computational Biology | 1 | 2017 | 20 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2010 | 193 | 0.130 |
Why?
|
| Alternative Splicing | 1 | 2017 | 21 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2017 | 17 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 22 | 0.130 |
Why?
|
| ADAM Proteins | 1 | 2017 | 41 | 0.130 |
Why?
|
| Motor Activity | 1 | 2019 | 317 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 55 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2018 | 571 | 0.130 |
Why?
|
| Chicago | 1 | 2019 | 898 | 0.130 |
Why?
|
| Imidazoles | 1 | 2017 | 62 | 0.130 |
Why?
|
| Parkinson Disease | 1 | 2023 | 640 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 111 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2010 | 437 | 0.120 |
Why?
|
| Gene Expression | 3 | 2023 | 200 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1333 | 0.120 |
Why?
|
| Markov Chains | 1 | 2015 | 33 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 868 | 0.120 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 50 | 0.110 |
Why?
|
| Bayes Theorem | 1 | 2015 | 40 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 58 | 0.110 |
Why?
|
| Epidermal Growth Factor | 2 | 2010 | 26 | 0.100 |
Why?
|
| Risk Factors | 1 | 2019 | 2237 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2019 | 957 | 0.100 |
Why?
|
| Aging | 2 | 2019 | 1483 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 2 | 2023 | 38 | 0.090 |
Why?
|
| Adult | 3 | 2023 | 7662 | 0.090 |
Why?
|
| Middle Aged | 4 | 2018 | 8772 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 22 | 0.090 |
Why?
|
| Tyrosine | 1 | 2010 | 23 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 22 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 7 | 0.090 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 8 | 0.090 |
Why?
|
| Diseases in Twins | 1 | 2010 | 9 | 0.090 |
Why?
|
| Linear Models | 2 | 2023 | 240 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2010 | 145 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 263 | 0.080 |
Why?
|
| Cell Line | 1 | 2010 | 260 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3399 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2019 | 1806 | 0.080 |
Why?
|
| Mutation | 1 | 2010 | 341 | 0.080 |
Why?
|
| Phosphotyrosine | 1 | 2008 | 1 | 0.080 |
Why?
|
| Animals | 2 | 2019 | 3503 | 0.070 |
Why?
|
| Autopsy | 2 | 2019 | 334 | 0.070 |
Why?
|
| Neurons | 2 | 2021 | 332 | 0.070 |
Why?
|
| Computer Graphics | 1 | 2006 | 4 | 0.060 |
Why?
|
| Software | 1 | 2006 | 56 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 153 | 0.060 |
Why?
|
| Kinetics | 1 | 2006 | 178 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2023 | 10 | 0.050 |
Why?
|
| Base Sequence | 1 | 2023 | 105 | 0.050 |
Why?
|
| DNA | 1 | 2023 | 100 | 0.050 |
Why?
|
| Organ Size | 1 | 2023 | 94 | 0.050 |
Why?
|
| Protein Aggregates | 1 | 2023 | 5 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2023 | 11 | 0.050 |
Why?
|
| Adaptor Protein Complex 1 | 1 | 2023 | 5 | 0.050 |
Why?
|
| Adaptor Protein Complex beta Subunits | 1 | 2023 | 5 | 0.050 |
Why?
|
| Mitochondria | 1 | 2023 | 60 | 0.050 |
Why?
|
| RNA | 1 | 2023 | 39 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2023 | 37 | 0.050 |
Why?
|
| Neuropathology | 1 | 2023 | 79 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 64 | 0.050 |
Why?
|
| Alleles | 1 | 2021 | 204 | 0.040 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2020 | 5 | 0.040 |
Why?
|
| Actinin | 1 | 2020 | 7 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 10 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 11 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 19 | 0.040 |
Why?
|
| Epoxide Hydrolases | 1 | 2020 | 11 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2020 | 26 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 50 | 0.040 |
Why?
|
| Germinal Center | 1 | 2020 | 1 | 0.040 |
Why?
|
| SOXC Transcription Factors | 1 | 2020 | 1 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 42 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 63 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 51 | 0.040 |
Why?
|
| Thy-1 Antigens | 1 | 2019 | 1 | 0.040 |
Why?
|
| Sensory Gating | 1 | 2019 | 3 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2019 | 10 | 0.040 |
Why?
|
| Schizophrenic Psychology | 1 | 2019 | 13 | 0.040 |
Why?
|
| Nerve Net | 1 | 2019 | 38 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 93 | 0.040 |
Why?
|
| Sclerosis | 1 | 2019 | 67 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 214 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2019 | 120 | 0.040 |
Why?
|
| Microglia | 1 | 2019 | 139 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 143 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 110 | 0.040 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 118 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 368 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2019 | 77 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 13 | 0.040 |
Why?
|
| Memory | 1 | 2019 | 285 | 0.040 |
Why?
|
| Lewy Bodies | 1 | 2019 | 185 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 83 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2019 | 157 | 0.040 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2019 | 109 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 391 | 0.030 |
Why?
|
| Apolipoprotein E4 | 1 | 2019 | 251 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2017 | 11 | 0.030 |
Why?
|
| Hippocampus | 1 | 2019 | 266 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 288 | 0.030 |
Why?
|
| Exons | 1 | 2017 | 33 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 37 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 79 | 0.030 |
Why?
|
| Genome, Human | 1 | 2017 | 43 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 106 | 0.030 |
Why?
|
| Astrocytes | 1 | 2018 | 140 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 577 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 337 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1701 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 544 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 851 | 0.030 |
Why?
|
| Mice | 1 | 2019 | 1352 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1059 | 0.030 |
Why?
|
| Coenzyme A Ligases | 1 | 2011 | 5 | 0.020 |
Why?
|
| Homozygote | 1 | 2011 | 18 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 19 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 115 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 79 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2008 | 7 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 253 | 0.020 |
Why?
|
| Time Factors | 1 | 2008 | 1391 | 0.010 |
Why?
|